Diabetes, physical activity participation and exercise capacity in patients with schizophreniaVANCAMPFORT, Davy; DE HERT, Marc; SWEERS, Kim et al.Psychiatry and clinical neurosciences (Carlton. Print). 2013, Vol 67, Num 6, pp 451-459, issn 1323-1316, 9 p.Article

Reliability, minimal detectable changes, practice effects and correlates of the 6-min walk test in patients with schizophreniaVANCAMPFORT, Davy; PROBST, Michel; SWEERS, Kim et al.Psychiatry research (Print). 2011, Vol 187, Num 1-2, pp 62-67, issn 0165-1781, 6 p.Article

Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophreniaVANCAMPFORT, Davy; PROBST, Michel; SCHEEWE, Thomas et al.Schizophrenia research. 2011, Vol 129, Num 2-3, pp 122-127, issn 0920-9964, 6 p.Article

Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders: A Systematic Review and Meta-AnalysisMITCHELL, Alex J; VANCAMPFORT, Davy; SWEERS, Kim et al.Schizophrenia bulletin. 2013, Vol 39, Num 2, pp 306-318, issn 0586-7614, 13 p.Article

Quality Assessment of Physical Activity Recommendations Within Clinical Practice Guidelines for the Prevention and Treatment of Cardio-metabolic Risk Factors in People With SchizophreniaVANCAMPFORT, Davy; SWEERS, Kim; PROBST, Michel et al.Community mental health journal. 2011, Vol 47, Num 6, pp 703-710, issn 0010-3853, 8 p.Article

Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophreniaVANCAMPFORT, Davy; PROBST, Michel; SCHEEWE, Thomas et al.Psychiatry research (Print). 2013, Vol 207, Num 1-2, pp 25-32, issn 0165-1781, 8 p.Article

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia : A retrospective chart reviewDE HERT, Marc; SCHREURS, Vincent; SWEERS, Kim et al.Schizophrenia research. 2008, Vol 101, Num 1-3, pp 295-303, issn 0920-9964, 9 p.Article

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder: A Systematic Review and Exploratory Meta-AnalysisDE HERT, Marc; WEIPING YU; DETRAUX, Johan et al.CNS drugs. 2012, Vol 26, Num 9, pp 733-759, issn 1172-7047, 27 p.Article

Effects of cannabis use on age at onset in schizophrenia and bipolar disorderDE HERT, Marc; WAMPERS, Martien; JENDRICKO, Tihana et al.Schizophrenia research. 2011, Vol 126, Num 1-3, pp 270-276, issn 0920-9964, 7 p.Article